HEADER TRANSCRIPTION/PROTEIN BINDING/AGONIST 07-FEB-12 4DMA TITLE CRYSTAL STRUCTURE OF ERA LBD IN COMPLEX WITH RU100132 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 303-549; COMPND 5 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 6 3 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 11 CHAIN: E, F; COMPND 12 FRAGMENT: UNP RESIDUES 690-704; COMPND 13 SYNONYM: NCOA-1, NUCLEAR RECEPTOR COACTIVATOR PROTEIN 1, MNRC-1, COMPND 14 STEROID RECEPTOR COACTIVATOR 1, SRC-1; COMPND 15 EC: 2.3.1.48; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 13 ORGANISM_COMMON: MOUSE; SOURCE 14 ORGANISM_TAXID: 10090 KEYWDS TRANSCRIPTION, NUCLEAR RECEPTOR, ER, ESTROGEN RECEPTOR, ALPHA HELICAL KEYWDS 2 SANDWICH, TRANSCRIPTION FACTOR, ESTRADIOL, TRANSCRIPTION-PROTEIN KEYWDS 3 BINDING-AGONIST COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.OSZ,Y.BRELIVET,C.PELUSO-ILTIS,V.CURA,S.EILER,M.RUFF,W.BOURGUET, AUTHOR 2 N.ROCHEL,D.MORAS REVDAT 4 28-FEB-24 4DMA 1 REMARK REVDAT 3 19-FEB-20 4DMA 1 JRNL REMARK SEQADV REVDAT 2 16-MAY-12 4DMA 1 JRNL REVDAT 1 07-MAR-12 4DMA 0 JRNL AUTH J.OSZ,Y.BRELIVET,C.PELUSO-ILTIS,V.CURA,S.EILER,M.RUFF, JRNL AUTH 2 W.BOURGUET,N.ROCHEL,D.MORAS JRNL TITL STRUCTURAL BASIS FOR A MOLECULAR ALLOSTERIC CONTROL JRNL TITL 2 MECHANISM OF COFACTOR BINDING TO NUCLEAR RECEPTORS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 109 E588 2012 JRNL REFN ISSN 0027-8424 JRNL PMID 22355136 JRNL DOI 10.1073/PNAS.1118192109 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH V.CURA,M.GANGLOFF,S.EILER,D.MORAS,M.RUFF REMARK 1 TITL CLEAVED THIOREDOXIN FUSION PROTEIN ENABLES THE REMARK 1 TITL 2 CRYSTALLIZATION OF POORLY SOLUBLE ERALPHA IN COMPLEX WITH REMARK 1 TITL 3 SYNTHETIC LIGANDS. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.F V. 64 54 2008 REMARK 1 REFN ESSN 1744-3091 REMARK 1 PMID 18097104 REMARK 1 DOI 10.1107/S1744309107066444 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 18877 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2067 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3978 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 120 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.150 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4DMA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1000070507. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0093 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18877 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20%(W/V) PEG 3350, 80 MM MGCL2, 100 MM REMARK 280 TRIS, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 297K, PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.89400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU B 1462 REMARK 465 SER B 1463 REMARK 465 SER B 1464 REMARK 465 THR B 1465 REMARK 465 LEU B 1466 REMARK 465 LYS B 1467 REMARK 465 SER B 1468 REMARK 465 LEU B 1469 REMARK 465 GLU B 1470 REMARK 465 GLU B 1471 REMARK 465 LYS B 1472 REMARK 465 LEU B 1549 REMARK 465 ARG E 686 REMARK 465 SER E 698 REMARK 465 PRO E 699 REMARK 465 SER E 700 REMARK 465 SER F 698 REMARK 465 PRO F 699 REMARK 465 SER F 700 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG F 686 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 408 81.49 -153.00 REMARK 500 PRO A 535 165.35 -48.92 REMARK 500 THR B1460 27.38 -73.99 REMARK 500 ASN B1532 70.52 58.02 REMARK 500 VAL B1533 -91.58 -118.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0L8 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0L8 B 1701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF NUCLEAR RECEPTOR REMARK 800 COACTIVATOR 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1G50 RELATED DB: PDB REMARK 900 RELATED ID: 4DM8 RELATED DB: PDB REMARK 900 RELATED ID: 4DM6 RELATED DB: PDB DBREF 4DMA A 303 549 UNP P03372 ESR1_HUMAN 303 549 DBREF 4DMA B 1303 1549 UNP P03372 ESR1_HUMAN 303 549 DBREF 4DMA E 686 700 UNP P70365 NCOA1_MOUSE 690 704 DBREF 4DMA F 686 700 UNP P70365 NCOA1_MOUSE 690 704 SEQADV 4DMA ALA A 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 4DMA ALA B 1530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQRES 1 A 247 LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET SEQRES 2 A 247 VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SEQRES 3 A 247 SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER SEQRES 4 A 247 MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU SEQRES 5 A 247 VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE SEQRES 6 A 247 VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SEQRES 7 A 247 CYS ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP SEQRES 8 A 247 ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO SEQRES 9 A 247 ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU SEQRES 10 A 247 GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SEQRES 11 A 247 SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE SEQRES 12 A 247 VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL SEQRES 13 A 247 TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU SEQRES 14 A 247 LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP SEQRES 15 A 247 THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU SEQRES 16 A 247 GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE SEQRES 17 A 247 LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU SEQRES 18 A 247 HIS LEU TYR SER MET LYS ALA LYS ASN VAL VAL PRO LEU SEQRES 19 A 247 TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU SEQRES 1 B 247 LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET SEQRES 2 B 247 VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SEQRES 3 B 247 SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER SEQRES 4 B 247 MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU SEQRES 5 B 247 VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE SEQRES 6 B 247 VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SEQRES 7 B 247 CYS ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP SEQRES 8 B 247 ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO SEQRES 9 B 247 ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU SEQRES 10 B 247 GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SEQRES 11 B 247 SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE SEQRES 12 B 247 VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL SEQRES 13 B 247 TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU SEQRES 14 B 247 LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP SEQRES 15 B 247 THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU SEQRES 16 B 247 GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE SEQRES 17 B 247 LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU SEQRES 18 B 247 HIS LEU TYR SER MET LYS ALA LYS ASN VAL VAL PRO LEU SEQRES 19 B 247 TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU SEQRES 1 E 15 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER SEQRES 2 E 15 PRO SER SEQRES 1 F 15 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER SEQRES 2 F 15 PRO SER HET 0L8 A 701 21 HET 0L8 B1701 21 HETNAM 0L8 2'-BROMO-6'-(FURAN-3-YL)-4'-(HYDROXYMETHYL)BIPHENYL-4- HETNAM 2 0L8 OL FORMUL 5 0L8 2(C17 H13 BR O3) FORMUL 7 HOH *120(H2 O) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 338 LYS A 362 1 25 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 SER A 395 1 25 HELIX 6 6 ARG A 412 VAL A 418 5 7 HELIX 7 7 MET A 421 MET A 438 1 18 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 GLU A 470 ALA A 493 1 24 HELIX 10 10 THR A 496 ALA A 530 1 35 HELIX 11 11 TYR A 537 ALA A 546 1 10 HELIX 12 12 THR B 1311 GLU B 1323 1 13 HELIX 13 13 SER B 1338 ARG B 1363 1 26 HELIX 14 14 THR B 1371 MET B 1396 1 26 HELIX 15 15 ASN B 1413 VAL B 1418 5 6 HELIX 16 16 GLY B 1420 MET B 1438 1 19 HELIX 17 17 GLN B 1441 SER B 1456 1 16 HELIX 18 18 HIS B 1474 ALA B 1493 1 20 HELIX 19 19 THR B 1496 ASN B 1532 1 37 HELIX 20 20 TYR B 1537 ALA B 1546 1 10 HELIX 21 21 LYS E 688 GLU E 696 1 9 HELIX 22 22 LYS F 688 GLU F 696 1 9 SHEET 1 A 2 LEU A 402 ALA A 405 0 SHEET 2 A 2 LEU A 408 LEU A 410 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B1401 ALA B1405 0 SHEET 2 B 2 LEU B1408 ASP B1411 -1 O LEU B1410 N LEU B1402 CISPEP 1 ARG B 1335 PRO B 1336 0 -0.31 SITE 1 AC1 11 MET A 343 ALA A 350 GLU A 353 TRP A 383 SITE 2 AC1 11 LEU A 384 ARG A 394 LEU A 428 GLY A 521 SITE 3 AC1 11 HIS A 524 LEU A 540 HOH A 845 SITE 1 AC2 10 THR B1347 ALA B1350 GLU B1353 LEU B1387 SITE 2 AC2 10 MET B1421 LEU B1428 HIS B1524 LEU B1525 SITE 3 AC2 10 LEU B1540 HOH B1804 SITE 1 AC3 14 ILE A 358 LYS A 362 LEU A 372 GLN A 375 SITE 2 AC3 14 VAL A 376 GLU A 380 ASP A 538 GLU A 542 SITE 3 AC3 14 MET A 543 TYR B1331 PRO B1333 HOH E 801 SITE 4 AC3 14 HOH E 804 HOH E 806 CRYST1 56.282 81.788 58.303 90.00 111.17 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017768 0.000000 0.006881 0.00000 SCALE2 0.000000 0.012227 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018393 0.00000